Cronos Group Inc. (CRON)
TSX
Closed
Oct 8, 2026
Day's Range
4.4952 wk Range
3.23Overview - CRON - Cronos Group Inc.
Key Statistics
Valuation
Enterprise Value
1.35B
P/E (Trailing)
‪17.07‬
P/E (Forward)
‪-76.83‬
PEG Ratio
‪-0.08‬
Price / Sales (TTM)
‪9.48‬
Price / Book
‪1.12‬
EV / EBITDA
‪80.09‬
Profitability
Gross Margin
‪53.67%‬
Profit Margin
‪39.07%‬
Operating Margin
‪15.44%‬
Return on Assets
‪-0.09%‬
Return on Equity
‪7.04%‬
Ownership
Shares Outstanding
370.72M
Float
186.98M
Short % of Shares Outstanding
‪1.35%‬
Held by Insiders
‪49.14%‬
Held by Institutions
‪15.47%‬
Price stats
Beta
‪1.27‬
50-Day Avg
‪4.44‬
200-Day Avg
‪3.88‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
4 analysts
Average price target
‪CA$ 4.92‬Market Cap - CRON - Cronos Group Inc.
Peers - CRON - Cronos Group Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on TSX.
- CRONTSXCronos Group Inc.1.69BMarket Cap+22.78%52-week change17.07P/E (Trailing)‪39.07%‬Profit Margin
- MRKTSXMerck & Co., Inc.509.66BMarket Cap+46.01%52-week change118.14P/E (Trailing)‪74.80%‬Profit Margin
- DPMTSXDPM Metals Inc.13.88BMarket Cap+50.96%52-week change14.53P/E (Trailing)‪50.26%‬Profit Margin
- CURATSXCuraleaf Holdings, Inc.4.13BMarket Cap+14.70%52-week change-14.88P/E (Trailing)‪-2.62%‬Profit Margin
- PBHTSXPremium Brands Holdings Corp3.66BMarket Cap-35.66%52-week change105.22P/E (Trailing)‪1.00%‬Profit Margin
- BHCTSXBausch Health Companies Inc.3.22BMarket Cap+1.50%52-week change13.44P/E (Trailing)‪-10.11%‬Profit Margin
- FDYTSXFaraday Copper Corp.1.61BMarket Cap+69.34%52-week change-45.67P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - CRON - Cronos Group Inc.
About
Cronos Group Inc. is a cannabinoid company focused on the cultivation, production, distribution, and marketing of cannabis products. The company serves adult-use and medical cannabis markets in Canada and Israel, while also reaching international customers through a portfolio of branded products. Its offerings include…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
